Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Regeneus Ltd. ( (AU:CMB) ) is now available.
Cambium Bio Limited has announced the appointment of Denese Marks as a new director, effective from May 21, 2025. This appointment is part of the company’s ongoing efforts to strengthen its leadership team and enhance its strategic direction, potentially impacting its operations and market positioning.
More about Regeneus Ltd.
Average Trading Volume: 19,808
Technical Sentiment Signal: Sell
Current Market Cap: A$3.47M
For detailed information about CMB stock, go to TipRanks’ Stock Analysis page.